Xin Yin

Ms. Xin Yin

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2022 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
XYXin Yin
Xin Yin
QYQi‐Qing Ye
Qi‐Qing Ye
KWKe‐Fan Wu
Ke‐Fan Wu
JZJi‐Yuan Zeng
Ji‐Yuan Zeng
NLNan‐Xi Li
Nan‐Xi Li
XGXu-Guang Guo
Xu-Guang Guo
Objectives: Even today, tuberculosis (TB) remains a leading public health problem; yet, the current diagnostic methods still have a few shortcomings. Lipoarabinomannan (LAM) provides an opportunity for TB diagnosis, and urine LAM detection seems to have a promising and widely applicable prospect.Design or methods: Four databases were systematically searched for eligible studies, and the quality of the studies was evaluated using the quality assessment of diagnostic accuracy studies‐2 (QUADAS‐2). Graphs and tables were created to show sensitivity, specificity, likelihood ratios, diagnostic odds ratio (DOR), the area under the curve (AUC), and so on.Results: Based on the included 67 studies, the pooled sensitivity of urine LAM was 48% and specificity was 89%. In the subgroup analyses, the FujiLAM test had higher sensitivity (69%) and specificity (92%). Furthermore, among patients infected with human immunodeficiency virus (HIV), 50% of TB patients were diagnosed using a urine LAM test. Besides, the CD4+ cell count was inversely proportional to the sensitivity.Conclusions: Urine LAM is a promising diagnostic test for TB, particularly using the FujiLAM in HIV‐infected adults whose CD4+ cell count is ≤100 per μl. Besides, the urine LAM test shows various sensitivities and specificities in different subgroups in terms of age, HIV infection status, CD4+ cell count, and testing method.

14 November 2022 in International Journal of Genomics
Verified
Journal Article
Open access
PDF file
XQXi-Feng Qian
Xi-Feng Qian
JZJia-Hao Zhang
Jia-Hao Zhang
YMYue-Xue Mai
Yue-Xue Mai
XYXin Yin
Xin Yin
YZYu-Bin Zheng
Yu-Bin Zheng
XGXu-Guang Guo
Xu-Guang Guo
Lower-grade gliomas (LGG) are the most common intracranial malignancies that readily evolve to high-grade gliomas and increase drug resistance. Paraptosis is defined as a nonapoptotic form of programmed cell death, which is gradually focused on patients with gliomas to develop treatment options. However, the specific role of paraptosis in LGG and its correlation is still vague. In this study, we first establish the novel paraptosis-based prognostic model for LGG patients. The relevant data of LGG patients were acquired from The Cancer Genome Atlas database, and we found that LGG patients could be divided into three different clusters based on paraptosis via consensus cluster analysis. Through least absolute shrinkage and selection operator regression analysis and multivariate Cox regression analysis, 10-paraptosis-related gene (PRG) signatures (CDK4, TNK2, DSTYK, CDKN3, CCR4, CASP9, HSPA5, RGR, LPAR1, and PDCD6IP) were identified to separate LGG patients into high- and low-risk subgroups successfully. The Kaplan–Meier analysis and time-dependent receiver-operating characteristic showed that the performances of predicting overall survival (OS) were dramatically high. The parallel results were reappeared and verified by using the Chinese Glioma Genome Atlas and Gene Expression Omnibus databases. Independent prognostic analysis and nomogram construction implied that risk scores could be considered the independent factor to predict OS. Enrichment analysis indicated that immune-related biological processes were generally enriched, and different immune statuses were highly infiltrated in high-risk group. We also confirmed the potential relationship of 10-PRG signatures and drug sensitivity of Food and Drug Administration–approved drugs. In summary, our findings provide a novel knowledge of paraptosis status and crucial direction to further explore the role of PRG signatures in LGG.

17 December 2021 in Journal of Clinical Laboratory Analysis
Verified
Journal Article
Open access
PDF file
YQYi‐Ran Qiu
Yi‐Ran Qiu
YCYu‐Yan Chen
Yu‐Yan Chen
XWXin‐Ran Wu
Xin‐Ran Wu
YLYa‐Ping Li
Ya‐Ping Li
XCXun‐Jie Cao
Xun‐Jie Cao
XGXu-Guang Guo
Xu-Guang Guo
Background: Tuberculosis poses a severe threat to human health. At present, compared with the traditional diagnostic methods for tuberculosis pleural effusion, such as Löwenstein–Jensen culture, pleural biopsy, and Ziehl–Neelsen smear microscopy, Xpert MTB/RIF was regarded as an emerging technology for its efficiency. The Xpert MTB/RIF accuracy for tuberculous pleural effusion diagnosis was evaluated in this systematic study.Materials and methods: We searched the relevant literature published before January 2021 in PubMed, Cochrane, EMBASE, and Web of Science databases. Utilizing Review Manager 5.3 software, the quality of the included literature was evaluated based on the Quality Assessment of Diagnostic Accuracy Studies criteria. Sensitivity, specificity, and the summary receiver operating characteristic curves were plotted and analyzed with Metadisc 1.40 software. We used Stata 12.0 software to evaluate the publication bias of this study.Results: Eighteen articles were identified in total. The sensitivity of Xpert MTB/RIF in the pleural effusion was 0.24, and specificity was 1.00, respectively. The area under the summary receiver operating characteristic curve was 0.9737, which indicated that the overall accuracy of the Xpert MTB/RIF was high. In addition, based on the Deeks funnel plot, no publication bias of the study was found.Conclusion: Xpert MTB/RIF is a rapid method with high specificity but relatively low sensitivity for detecting Mycobacterium tuberculosis in pleural effusion. Its less sensitivity made it difficult to be used clinically, but the high specificity suggests that it can be used as a specific diagnostic method for tuberculous pleural effusion.

1 January 2022 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
PHPei-Ying Huang
Pei-Ying Huang
XYXin Yin
Xin Yin
YHYue-Ting Huang
Yue-Ting Huang
QYQi-Qing Ye
Qi-Qing Ye
SCSi-Qing Chen
Si-Qing Chen
XGXu-Guang Guo
Xu-Guang Guo
Huang PY, et al. Yonsei Med J. 2022 May;63(5):480-489. https://doi.org/10.3349/ymj.2022.63.5.480

6 June 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
QYQi-Qing Ye
Qi-Qing Ye
SKShao-Min Kong
Shao-Min Kong
XYXin Yin
Xin Yin
CGChang Gao
Chang Gao
MLMin-Shan Lu
Min-Shan Lu
XQXiu Qiu
Xiu Qiu
We aimed to examine the associations between cord blood lipids and childhood adiposity and to investigate whether these associations vary across birth weight categories (small for gestational age (SGA), appropriate for gestational age (AGA) and large for gestational age (LGA)) in 1306 infants in the Born in Guangzhou Cohort Study, China. Adiposity outcomes at the age of three years included z-scores of weight-for-length/height (WFLZ), body mass index (BMIZ), subscapular (SSTZ) and triceps skinfold thickness (TSTZ), and the sum of skinfold thicknesses (SSFTZ). Cord blood triglycerides (TG) levels were negatively associated with WFLZ and BMIZ, whereas high density lipoprotein (HDL) levels were positively associated with WFLZ, BMIZ, TSTZ and SSFTZ. These associations were attenuated after adjustment for birth weight. Stratified analyses revealed that total cholesterol (TC) and low-density lipoprotein (LDL) levels were positively associated with childhood adiposity indicators among AGA infants but tended to be negatively associated with the adiposity indicators among LGA infants (p values for interaction <0.05). Furthermore, TG levels appeared to be positively associated with adiposity indicators among SGA infants but negatively associated with the outcomes among LGA infants (p values for interaction <0.05). Cord blood lipids levels might be associated with childhood adiposity, and these associations appear to differ across different birth weight categories. If confirmed in future studies, our findings suggest that individualized management plans might be warranted in preventing obesity.

1 January 2022 in Yonsei Medical Journal
Verified
Journal Article
Open access
PDF file
LXLi-Min Xie
Li-Min Xie
XYXin Yin
Xin Yin
TXTian-Ao Xie
Tian-Ao Xie
JSJian-Wen Su
Jian-Wen Su
QHQin Huang
Qin Huang
XGXu-Guang Guo
Xu-Guang Guo
Xie LM, et al. Yonsei Med J. 2022 Jan;63(1):95-103. https://doi.org/10.3349/ymj.2022.63.1.95